在母乳养期间治疗注意力缺陷多动障碍和儿童神经发育结果的安非他林使用:试点研究
Nofar Benassayag Kaduri1, Ariela Hazan1, Tal De-Haan1
1Clinical Pharmacology and Toxicology Unit, Drug Consultation Center, Shamir Medical Center (Assaf Harofeh), Zerifin, Affiliated to Faculty of Medicine & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
对于注意力缺陷多动障碍 (ADHD) 的安非他命兴奋剂在母乳养期间可能是安全的. 一项针对13名婴儿的小型研究显示,神经发育正常,没有任何不良影响,但需要进行更大规模的研究.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经发育障碍 神经发育障碍
- 儿科 儿科 儿科
背景情况:
- 注意力缺陷多动症 (ADHD) 药物使用在生育年龄和怀孕期间的妇女中正在增加.
- 关于安非他胺兴奋剂在哺乳母亲的ADHD治疗中的安全性数据有限.
- 现有的安全数据往往来自于对娱乐性甲基胺滥用的研究,而不是治疗用途.
研究的目的:
- 评估通过母乳养暴露于安非他胺兴奋剂的婴儿的安全性和神经发育结果.
- 为ADHD兴奋剂药物与母乳养的兼容性提供初步证据.
主要方法:
- 研究人员跟踪了一组13名儿童,这些儿童在母乳养期间接触过胺兴奋剂.
- 用儿科生活质量和丹佛发育量表来评估神经发育和结果.
主要成果:
- 研究中的所有儿童都表现出正常的神经发育.
- 在暴露的婴儿中没有观察到任何显著的不良影响.
- 初步发现表明,通过母乳暴露于安非他因缺乏直接危害.
结论:
- 胺兴奋剂可能与母乳养兼容,用于治疗ADHD.
- 需要进行更大规模的研究来证实这些初步发现,并制定最终的安全指南.
- 需要进一步的研究,以充分了解哺乳期刺激剂暴露的长期影响.
更多相关视频
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
相关概念视频
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
